Skip to main content
EJNMMI Research

Table 1 Prospective studies currently recruiting for Anti-PD1 treatment in Glioblastoma

From: Imaging-guided precision medicine in glioblastoma patients treated with immune checkpoint modulators: research trend and future directions in the field of imaging biomarkers and artificial intelligence

  1. Note: Details on clinical trials were obtained on ClinicalTrials.gov website (https://clinicaltrials.gov/ct2/home). Last upadate, December 1, 2018. IDO-1 cytosolic enzyme indoleamine 2,3-dioxygenase-1, TTF Tumor treating Fields, TIL tumor infiltrating lymphocytes, GITR Glucocorticoid induced TNF receptor, ND not discolsed, DCE: dynamic contrast-enhanced
Back to article page